Salivary Metabolites in Patients with Mucopolysaccharidosis

ABSTRACT Objective: To identify the salivary metabolites profile of Mucopolysaccharidosis (MPS) types I, II, IV, and VI patients. Material and Methods: The participants were asked to refrain from eating and drinking for one hour before sampling, performed between 7:30 and 9:00 a.m. Samples were cent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pesquisa brasileira em odontopediatria e clínica integrada 2024, Vol.24
Hauptverfasser: Torres, Rafaela de Oliveira, Pintor, Andréa Vaz Braga, Fidalgo, Tatiana Kelly da Silva, Valente, Ana Paula Canedo, Freitas-Fernandes, Liana Bastos, Souza, Ivete Pomarico Ribeiro de
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Pesquisa brasileira em odontopediatria e clínica integrada
container_volume 24
creator Torres, Rafaela de Oliveira
Pintor, Andréa Vaz Braga
Fidalgo, Tatiana Kelly da Silva
Valente, Ana Paula Canedo
Freitas-Fernandes, Liana Bastos
Souza, Ivete Pomarico Ribeiro de
description ABSTRACT Objective: To identify the salivary metabolites profile of Mucopolysaccharidosis (MPS) types I, II, IV, and VI patients. Material and Methods: The participants were asked to refrain from eating and drinking for one hour before sampling, performed between 7:30 and 9:00 a.m. Samples were centrifuged at 10.000 × g for 60 min at 4°C, and the supernatants (500µl) were stored at −80°C until NMR analysis. The salivary proton nuclear magnetic resonance (1H-NMR) spectra were acquired in a 500 MHz spectrometer, and TOCSY experiments were used to confirm and assign metabolites. Data were analyzed descriptively. Results: Differences in salivary metabolites were found among MPS types and the control, such as lactate, propionate, alanine, and N-acetyl sugar. Understanding these metabolite changes may contribute to precision medicine and early detection of mucopolysaccharidosis and its monitoring. Conclusion: The composition of low molecular weight salivary metabolites of mucopolysaccharidosis subjects may present specific features compared to healthy controls.
doi_str_mv 10.1590/pboci.2024.011
format Article
fullrecord <record><control><sourceid>scielo_cross</sourceid><recordid>TN_cdi_scielo_journals_S1983_46322024000100313</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><scielo_id>S1983_46322024000100313</scielo_id><sourcerecordid>S1983_46322024000100313</sourcerecordid><originalsourceid>FETCH-LOGICAL-c273t-289a22f2f534fd3072f4cc616d08c12c21e1874cdd30a18ea9ebd393433580753</originalsourceid><addsrcrecordid>eNpFkE1LxDAQhoMouK5ePfcPtM5kmjbFkyx-wS4Kq-eQpimbpTalySr7721V8DQDw_sOz8PYNUKGooKbofbGZRx4ngHiCVtgJSnNC-Kn0y6wSkEAnrOLEPYAQiIUC3a71Z371OMx2dioa9-5aEPi-uRVR2f7GJIvF3fJ5mD84Ltj0Mbs9OgaH1y4ZGet7oK9-ptL9v5w_7Z6Stcvj8-ru3VqeEkx5bLSnLe8FZS3DUHJ29yYAosGpEFuOFqUZW6a6aZRWl3ZuqGKciIhoRS0ZNlvbzDOdl7t_WHsp4dqOxOqmXCmBgAEIKT_gBl9CKNt1TC6jwlSIajZlfpxpeaUmlzRNxz8Wuw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Salivary Metabolites in Patients with Mucopolysaccharidosis</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Torres, Rafaela de Oliveira ; Pintor, Andréa Vaz Braga ; Fidalgo, Tatiana Kelly da Silva ; Valente, Ana Paula Canedo ; Freitas-Fernandes, Liana Bastos ; Souza, Ivete Pomarico Ribeiro de</creator><creatorcontrib>Torres, Rafaela de Oliveira ; Pintor, Andréa Vaz Braga ; Fidalgo, Tatiana Kelly da Silva ; Valente, Ana Paula Canedo ; Freitas-Fernandes, Liana Bastos ; Souza, Ivete Pomarico Ribeiro de</creatorcontrib><description>ABSTRACT Objective: To identify the salivary metabolites profile of Mucopolysaccharidosis (MPS) types I, II, IV, and VI patients. Material and Methods: The participants were asked to refrain from eating and drinking for one hour before sampling, performed between 7:30 and 9:00 a.m. Samples were centrifuged at 10.000 × g for 60 min at 4°C, and the supernatants (500µl) were stored at −80°C until NMR analysis. The salivary proton nuclear magnetic resonance (1H-NMR) spectra were acquired in a 500 MHz spectrometer, and TOCSY experiments were used to confirm and assign metabolites. Data were analyzed descriptively. Results: Differences in salivary metabolites were found among MPS types and the control, such as lactate, propionate, alanine, and N-acetyl sugar. Understanding these metabolite changes may contribute to precision medicine and early detection of mucopolysaccharidosis and its monitoring. Conclusion: The composition of low molecular weight salivary metabolites of mucopolysaccharidosis subjects may present specific features compared to healthy controls.</description><identifier>ISSN: 1519-0501</identifier><identifier>ISSN: 1983-4632</identifier><identifier>EISSN: 1983-4632</identifier><identifier>DOI: 10.1590/pboci.2024.011</identifier><language>eng</language><publisher>Associação de Apoio à Pesquisa em Saúde Bucal</publisher><subject>DENTISTRY, ORAL SURGERY &amp; MEDICINE</subject><ispartof>Pesquisa brasileira em odontopediatria e clínica integrada, 2024, Vol.24</ispartof><rights>This work is licensed under a Creative Commons Attribution 4.0 International License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c273t-289a22f2f534fd3072f4cc616d08c12c21e1874cdd30a18ea9ebd393433580753</cites><orcidid>0000-0001-7219-1123 ; 0000-0003-1340-9967 ; 0000-0003-0449-6624 ; 0000-0002-3323-7691 ; 0000-0002-8560-6356 ; 0000-0002-5892-6792</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,861,882,4010,27904,27905,27906</link.rule.ids></links><search><creatorcontrib>Torres, Rafaela de Oliveira</creatorcontrib><creatorcontrib>Pintor, Andréa Vaz Braga</creatorcontrib><creatorcontrib>Fidalgo, Tatiana Kelly da Silva</creatorcontrib><creatorcontrib>Valente, Ana Paula Canedo</creatorcontrib><creatorcontrib>Freitas-Fernandes, Liana Bastos</creatorcontrib><creatorcontrib>Souza, Ivete Pomarico Ribeiro de</creatorcontrib><title>Salivary Metabolites in Patients with Mucopolysaccharidosis</title><title>Pesquisa brasileira em odontopediatria e clínica integrada</title><addtitle>Pesqui. Bras. Odontopediatria Clín. Integr</addtitle><description>ABSTRACT Objective: To identify the salivary metabolites profile of Mucopolysaccharidosis (MPS) types I, II, IV, and VI patients. Material and Methods: The participants were asked to refrain from eating and drinking for one hour before sampling, performed between 7:30 and 9:00 a.m. Samples were centrifuged at 10.000 × g for 60 min at 4°C, and the supernatants (500µl) were stored at −80°C until NMR analysis. The salivary proton nuclear magnetic resonance (1H-NMR) spectra were acquired in a 500 MHz spectrometer, and TOCSY experiments were used to confirm and assign metabolites. Data were analyzed descriptively. Results: Differences in salivary metabolites were found among MPS types and the control, such as lactate, propionate, alanine, and N-acetyl sugar. Understanding these metabolite changes may contribute to precision medicine and early detection of mucopolysaccharidosis and its monitoring. Conclusion: The composition of low molecular weight salivary metabolites of mucopolysaccharidosis subjects may present specific features compared to healthy controls.</description><subject>DENTISTRY, ORAL SURGERY &amp; MEDICINE</subject><issn>1519-0501</issn><issn>1983-4632</issn><issn>1983-4632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpFkE1LxDAQhoMouK5ePfcPtM5kmjbFkyx-wS4Kq-eQpimbpTalySr7721V8DQDw_sOz8PYNUKGooKbofbGZRx4ngHiCVtgJSnNC-Kn0y6wSkEAnrOLEPYAQiIUC3a71Z371OMx2dioa9-5aEPi-uRVR2f7GJIvF3fJ5mD84Ltj0Mbs9OgaH1y4ZGet7oK9-ptL9v5w_7Z6Stcvj8-ru3VqeEkx5bLSnLe8FZS3DUHJ29yYAosGpEFuOFqUZW6a6aZRWl3ZuqGKciIhoRS0ZNlvbzDOdl7t_WHsp4dqOxOqmXCmBgAEIKT_gBl9CKNt1TC6jwlSIajZlfpxpeaUmlzRNxz8Wuw</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>Torres, Rafaela de Oliveira</creator><creator>Pintor, Andréa Vaz Braga</creator><creator>Fidalgo, Tatiana Kelly da Silva</creator><creator>Valente, Ana Paula Canedo</creator><creator>Freitas-Fernandes, Liana Bastos</creator><creator>Souza, Ivete Pomarico Ribeiro de</creator><general>Associação de Apoio à Pesquisa em Saúde Bucal</general><scope>AAYXX</scope><scope>CITATION</scope><scope>GPN</scope><orcidid>https://orcid.org/0000-0001-7219-1123</orcidid><orcidid>https://orcid.org/0000-0003-1340-9967</orcidid><orcidid>https://orcid.org/0000-0003-0449-6624</orcidid><orcidid>https://orcid.org/0000-0002-3323-7691</orcidid><orcidid>https://orcid.org/0000-0002-8560-6356</orcidid><orcidid>https://orcid.org/0000-0002-5892-6792</orcidid></search><sort><creationdate>2024</creationdate><title>Salivary Metabolites in Patients with Mucopolysaccharidosis</title><author>Torres, Rafaela de Oliveira ; Pintor, Andréa Vaz Braga ; Fidalgo, Tatiana Kelly da Silva ; Valente, Ana Paula Canedo ; Freitas-Fernandes, Liana Bastos ; Souza, Ivete Pomarico Ribeiro de</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c273t-289a22f2f534fd3072f4cc616d08c12c21e1874cdd30a18ea9ebd393433580753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>DENTISTRY, ORAL SURGERY &amp; MEDICINE</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Torres, Rafaela de Oliveira</creatorcontrib><creatorcontrib>Pintor, Andréa Vaz Braga</creatorcontrib><creatorcontrib>Fidalgo, Tatiana Kelly da Silva</creatorcontrib><creatorcontrib>Valente, Ana Paula Canedo</creatorcontrib><creatorcontrib>Freitas-Fernandes, Liana Bastos</creatorcontrib><creatorcontrib>Souza, Ivete Pomarico Ribeiro de</creatorcontrib><collection>CrossRef</collection><collection>SciELO</collection><jtitle>Pesquisa brasileira em odontopediatria e clínica integrada</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Torres, Rafaela de Oliveira</au><au>Pintor, Andréa Vaz Braga</au><au>Fidalgo, Tatiana Kelly da Silva</au><au>Valente, Ana Paula Canedo</au><au>Freitas-Fernandes, Liana Bastos</au><au>Souza, Ivete Pomarico Ribeiro de</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Salivary Metabolites in Patients with Mucopolysaccharidosis</atitle><jtitle>Pesquisa brasileira em odontopediatria e clínica integrada</jtitle><addtitle>Pesqui. Bras. Odontopediatria Clín. Integr</addtitle><date>2024</date><risdate>2024</risdate><volume>24</volume><issn>1519-0501</issn><issn>1983-4632</issn><eissn>1983-4632</eissn><abstract>ABSTRACT Objective: To identify the salivary metabolites profile of Mucopolysaccharidosis (MPS) types I, II, IV, and VI patients. Material and Methods: The participants were asked to refrain from eating and drinking for one hour before sampling, performed between 7:30 and 9:00 a.m. Samples were centrifuged at 10.000 × g for 60 min at 4°C, and the supernatants (500µl) were stored at −80°C until NMR analysis. The salivary proton nuclear magnetic resonance (1H-NMR) spectra were acquired in a 500 MHz spectrometer, and TOCSY experiments were used to confirm and assign metabolites. Data were analyzed descriptively. Results: Differences in salivary metabolites were found among MPS types and the control, such as lactate, propionate, alanine, and N-acetyl sugar. Understanding these metabolite changes may contribute to precision medicine and early detection of mucopolysaccharidosis and its monitoring. Conclusion: The composition of low molecular weight salivary metabolites of mucopolysaccharidosis subjects may present specific features compared to healthy controls.</abstract><pub>Associação de Apoio à Pesquisa em Saúde Bucal</pub><doi>10.1590/pboci.2024.011</doi><orcidid>https://orcid.org/0000-0001-7219-1123</orcidid><orcidid>https://orcid.org/0000-0003-1340-9967</orcidid><orcidid>https://orcid.org/0000-0003-0449-6624</orcidid><orcidid>https://orcid.org/0000-0002-3323-7691</orcidid><orcidid>https://orcid.org/0000-0002-8560-6356</orcidid><orcidid>https://orcid.org/0000-0002-5892-6792</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1519-0501
ispartof Pesquisa brasileira em odontopediatria e clínica integrada, 2024, Vol.24
issn 1519-0501
1983-4632
1983-4632
language eng
recordid cdi_scielo_journals_S1983_46322024000100313
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects DENTISTRY, ORAL SURGERY & MEDICINE
title Salivary Metabolites in Patients with Mucopolysaccharidosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A55%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-scielo_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Salivary%20Metabolites%20in%20Patients%20with%20Mucopolysaccharidosis&rft.jtitle=Pesquisa%20brasileira%20em%20odontopediatria%20e%20cl%C3%ADnica%20integrada&rft.au=Torres,%20Rafaela%20de%20Oliveira&rft.date=2024&rft.volume=24&rft.issn=1519-0501&rft.eissn=1983-4632&rft_id=info:doi/10.1590/pboci.2024.011&rft_dat=%3Cscielo_cross%3ES1983_46322024000100313%3C/scielo_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_scielo_id=S1983_46322024000100313&rfr_iscdi=true